Live from the NIH registry
Studies recruiting near Lancaster right now
Top 25 of 104 recruiting studies, sorted by proximity — each links to its official registry page
A Study of LY4005130 in Adult Participants With Non-Segmental Vitiligo
Vitiligo, Non-Segmental Vitiligo (NSV)
Phase 2
Interventional 66 participants sought
Cura Clinical Research - Santa Clarita - Kelly Johnson Parkway — Santa Clarita, California (29.5 mi)
· Sponsor: Eli Lilly and Company
A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition
Metabolic Dysfunction-Associated SteatoHepatitis (MASH)
Phase 2
Interventional 120 participants sought
Om Research Llc — Lancaster, California (2.2 mi)
· Sponsor: Regeneron Pharmaceuticals
Non-healing Venous Leg Ulcers Treated With Standard Care With or Without BR-AC
Non-infected Venous Leg Ulcer, Venous Leg Ulcer
N/A
Interventional 60 participants sought
Site 19 — Palmdale, California (8.6 mi)
· Sponsor: BioStem Technologies
A Study to Investigate Efficacy and Safety of Brivekimig in Participants With Crohn's Disease
Crohn's Disease
Phase 2
Interventional 99 participants sought
Investigational Site Number: 8400001 — Lancaster, California (2.2 mi)
· Sponsor: Sanofi
This Study Evaluates the ALPCO Syphilis-T and Syphilis-NT CLIA Kits for Detecting Syphilis Antibodies in Serum and Plasma. Samples From At-risk, HIV-positive, Pregnant, and Healthy Individuals Will Assess Assay Performance Versus Established Comparator Tests.
Treponema Pallidum, Treponema Pallidum Infection
N/A
Observational 1,000 participants sought
Chemidox Clinical Trials California — Lancaster, California (2.2 mi)
· Sponsor: American Laboratory Products Company
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
Biochemically Recurrent Prostate Carcinoma, Metastatic Prostate Carcinoma
Phase 3
Interventional 804 participants sought
City of Hope Antelope Valley — Lancaster, California (2.2 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
NASH - Nonalcoholic Steatohepatitis, MASH - Metabolic Dysfunction-Associated Steatohepatitis
Phase 3
Interventional 2,150 participants sought
Akero Clinical Study Site — Lancaster, California (2.2 mi)
· Sponsor: Akero Therapeutics, Inc
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
Heart Failure
Phase 3
Interventional 4,200 participants sought
Amicis Research Corporate — Santa Clarita, California (29.5 mi)
· Sponsor: Boehringer Ingelheim
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
Ovarian Carcinoma
N/A
Interventional 1,956 participants sought
City of Hope Antelope Valley — Lancaster, California (2.2 mi)
· Sponsor: NRG Oncology
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
Heart Failure
Phase 3
Interventional 6,712 participants sought
Amicis Research Center - Valencia — Santa Clarita, California (29.5 mi)
· Sponsor: Boehringer Ingelheim
Ultra-hypofractionated Whole Breast Irradiation With Lumpectomy Cavity Boost for the Treatment of Stage I-III Breast Cancer
Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8
Phase 2
Interventional 82 participants sought
City of Hope Antelope Valley — Lancaster, California (2.2 mi)
· Sponsor: City of Hope Medical Center
Clevidipine for the Antihypertensive Treatment of Acute Intracerebral Hemorrhage
Intracerebral Hemorrhage, Stroke
N/A
Observational 1,018 participants sought
Antelope Valley Medical Center — Lancaster, California (2.2 mi)
· Sponsor: Zeenat Qureshi Stroke Institute
A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease
Graves' Disease
Phase 2
Interventional 240 participants sought
Site Number - 1035 — Santa Clarita, California (29.5 mi)
· Sponsor: Immunovant Sciences GmbH
A Study to Investigate the Efficacy and Safety of SAR442970 in Adult Participants With Ulcerative Colitis
Ulcerative Colitis
Phase 2
Interventional 99 participants sought
Investigational Site Number: 8400006 — Lancaster, California (2.2 mi)
· Sponsor: Sanofi
Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures FOCUS-1
Focal Seizure, Epilepsy
Phase 3
Interventional 333 participants sought
Amicis Research Center — Palmdale, California (8.6 mi)
· Sponsor: Rapport Therapeutics Inc.
Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor Burden Follicular Lymphoma
Classic Follicular Lymphoma, Follicular Lymphoma With Unusual Cytological Features
Phase 3
Interventional 600 participants sought
City of Hope Antelope Valley — Lancaster, California (2.2 mi)
· Sponsor: National Cancer Institute (NCI)
A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
Moderately to Severely Active Crohns Disease
Phase 3
Interventional 425 participants sought
Om Research LLC — Lancaster, California (2.2 mi)
· Sponsor: Hoffmann-La Roche
A Study of KT-621 Administered Orally to Adult Participants With Moderate to Severe Eosinophilic Asthma
Eosinophilic Asthma
Phase 2
Interventional 264 participants sought
Kymera Investigative Site — Lancaster, California (2.2 mi)
· Sponsor: Kymera Therapeutics, Inc.
Contraceptive Efficacy Study of Ovaprene
Contraception
N/A
Interventional 656 participants sought
Amicis Research Center — Newhall, California (29.4 mi)
· Sponsor: Daré Bioscience, Inc.
Testing Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to the Brain
Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma
Phase 3
Interventional 269 participants sought
City of Hope Antelope Valley — Lancaster, California (2.2 mi)
· Sponsor: NRG Oncology
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
Metabolic Dysfunction-Associated Steatotic Liver Disease
Phase 3
Interventional 4,500 participants sought
Om Research LLC — Lancaster, California (2.2 mi)
· Sponsor: Eli Lilly and Company
A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes
Diabetes Mellitus, Type 2
Phase 2
Interventional 270 participants sought
First Valley Medical Group — Lancaster, California (2.2 mi)
· Sponsor: Novo Nordisk A/S
A Phase II Study to Investigate Lung Function With 2 Different Doses of Inhaled Glycopyrronium Taken With BFF Compared to BFF in Participants of 4 to Less Than 12 Years of Age With Asthma
Asthma
Phase 2
Interventional 69 participants sought
Research Site — Lancaster, California (2.2 mi)
· Sponsor: AstraZeneca
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
Prostate Cancer (Adenocarcinoma)
Phase 3
Interventional 830 participants sought
City of Hope Antelope Valley — Lancaster, California (2.2 mi)
· Sponsor: Canadian Cancer Trials Group
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
Crohn's Disease, Ulcerative Colitis
Phase 2
Interventional 2,000 participants sought
Gastro Care Institute /ID# 281071 — Lancaster, California (2.2 mi)
· Sponsor: AbbVie